Apellis Pharmaceuticals, Inc. Quarterly Current Ratio in % from Q2 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Apellis Pharmaceuticals, Inc. quarterly Current Ratio history and growth rate from Q2 2018 to Q3 2024.
  • Apellis Pharmaceuticals, Inc. Current Ratio for the quarter ending September 30, 2024 was 397 %, a 21.2% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 397 -107 -21.2% Sep 30, 2024
Q2 2024 396 -174 -30.6% Jun 30, 2024
Q1 2024 397 -235 -37.2% Mar 31, 2024
Q4 2023 457 -220 -32.5% Dec 31, 2023
Q3 2023 504 -241 -32.4% Sep 30, 2023
Q2 2023 570 -134 -19.1% Jun 30, 2023
Q1 2023 632 +30.5 +5.08% Mar 31, 2023
Q4 2022 676 +92.7 +15.9% Dec 31, 2022
Q3 2022 746 +138 +22.6% Sep 30, 2022
Q2 2022 704 +10.3 +1.48% Jun 30, 2022
Q1 2022 601 -351 -36.8% Mar 31, 2022
Q4 2021 584 -436 -42.8% Dec 31, 2021
Q3 2021 608 -450 -42.5% Sep 30, 2021
Q2 2021 694 -379 -35.3% Jun 30, 2021
Q1 2021 952 +34.1 +3.72% Mar 31, 2021
Q4 2020 1.02K +152 +17.5% Dec 31, 2020
Q3 2020 1.06K -24.7 -2.28% Sep 30, 2020
Q2 2020 1.07K -118 -9.9% Jun 30, 2020
Q1 2020 918 -681 -42.6% Mar 31, 2020
Q4 2019 868 -854 -49.6% Dec 31, 2019
Q3 2019 1.08K -1.04K -48.9% Sep 30, 2019
Q2 2019 1.19K -841 -41.4% Jun 30, 2019
Q1 2019 1.6K Mar 31, 2019
Q4 2018 1.72K Dec 31, 2018
Q3 2018 2.12K Sep 30, 2018
Q2 2018 2.03K Jun 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.